tiprankstipranks
Trending News
More News >
Alembic Pharmaceuticals Limited (IN:APLLTD)
:APLLTD
India Market

Alembic Pharmaceuticals Limited (APLLTD) Financial Statements

Compare
2 Followers

Alembic Pharmaceuticals Limited Financial Overview

Alembic Pharmaceuticals Limited's market cap is currently ₹157.23B. The company's EPS TTM is ₹9.4; its P/E ratio is 24.78; and it has a dividend yield of 1.28%. Alembic Pharmaceuticals Limited is scheduled to report earnings on November 4, 2025, and the estimated EPS forecast is ₹8.37. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue₹ 66.72B₹ 62.29B₹ 56.53B₹ 53.06B₹ 53.93B
Gross Profit₹ 47.91B₹ 44.33B₹ 38.78B₹ 38.08B₹ 40.53B
Operating Income₹ 27.02B₹ 25.08B₹ 19.81B₹ 18.31B₹ 23.32B
EBITDA₹ 9.89B₹ 9.14B₹ 6.96B₹ 8.59B₹ 14.66B
Net Income₹ 5.83B₹ 6.16B₹ 3.42B₹ 5.21B₹ 11.46B
Balance Sheet
Cash & Short-Term Investments₹ 901.00M₹ 1.20B₹ 754.80M₹ 610.90M₹ 2.85B
Total Assets₹ 77.73B₹ 64.46B₹ 61.83B₹ 71.22B₹ 67.09B
Total Debt₹ 12.57B₹ 5.13B₹ 7.22B₹ 7.17B₹ 5.84B
Net Debt₹ 11.67B₹ 3.93B₹ 6.47B₹ 6.56B₹ 4.86B
Total Liabilities₹ 25.83B₹ 16.27B₹ 18.12B₹ 18.84B₹ 16.42B
Stockholders' Equity₹ 51.91B₹ 48.18B₹ 43.70B₹ 52.38B₹ 50.67B
Cash Flow
Free Cash Flow₹ -4.76B₹ 4.76B₹ 2.81B₹ 1.27B₹ 8.04B
Operating Cash Flow₹ 879.70M₹ 8.03B₹ 7.24B₹ 5.52B₹ 14.63B
Investing Cash Flow₹ -5.68B₹ -3.21B₹ -4.48B₹ -3.72B₹ -8.39B
Financing Cash Flow₹ 4.44B₹ -4.38B₹ -2.62B₹ -2.17B₹ -5.97B
Currency in INR

Alembic Pharmaceuticals Limited Earnings and Revenue History

Alembic Pharmaceuticals Limited Debt to Assets

Alembic Pharmaceuticals Limited Cash Flow

Alembic Pharmaceuticals Limited Forecast EPS vs Actual EPS